Biomarkers indicating raised inflammatory activity, e.g., C-reactive protein (CRP) and interleukin 6 (IL-6), have been associated with an increased risk of future cardiovascular disease in healthy individuals, in patients with stable and unstable coronary artery disease, and in congestive heart failure patients [19,20]. The gene discussed is IL6; the disease is cardiovascular disorder.